ArticleJournal of medical case reports2025
Meningoencephalitis as a presentation of primary Sjögren's syndrome: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSjögren's syndrome is an autoimmune, chronic inflammatory disease characterized by its impact on salivary and lacrimal glands, along with potential involvement of internal organs. Sicca symptoms, such as dry eyes and mouth, are typical features. CASE PRESENTATION: We present the case of a 30-year-old Iraqi woman who presented with meningoencephalitis and acute motor axonal neuropathy, which were unusual as initial manifestations of Sjögren's syndrome. Initial investigations included a complete blood count, erythrocyte sedimentation rate, C-reactive protein, renal and liver function tests, and cerebrospinal fluid analysis. Brain magnetic resonance imaging showed hyperintense lesions in the brainstem and periventricular regions, and magnetic resonance venography was performed to rule out venous thrombosis. An aquaporin 4 antibody screening test was sent for suspected neuromyelitis optica and returned positive. However, subsequent magnetic resonance imaging scans of the spinal cord and optic nerve found no abnormalities. Serological tests confirmed the presence of antinuclear antibodies, rheumatoid factor, and antibodies against SS-A and SS-B, consistent with Sjögren's syndrome. The patient was treated with methylprednisolone and intravenous immunoglobulin. Given the suspected diagnosis of Bickerstaff encephalitis, intravenous immunoglobulin was included in the regimen, although it was later ruled out. After 4 weeks of treatment, the patient showed significant improvement, regaining consciousness and partial motor function. Several months after symptom onset, the patient achieved independent mobility despite experiencing mild weakness in the right lower limb, and plans were made to initiate either cyclophosphamide or rituximab therapy.
conclusionsThis case underscores the diverse clinical presentations of Sjögren's syndrome, highlighting the importance of considering autoimmune etiologies in patients presenting with neurological manifestations such as meningoencephalitis and acute motor axonal neuropathy. Early recognition and management of such atypical presentations are crucial for improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.